Skin disease manifestations in systemic lupus erythematosus do not have an impact on disease severity, according to a study.“Skin manifestations of systemic lupus erythematosus are myriad and ...

Lupus affects different people in different ways, and skin problems like rashes or sores re common. In a new study, people with systemic lupus erythematosus (SLE) were found to be at higher risk for ...

Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high ...

Systemic Lupus Erythematosus is an autoimmune disease affecting multiple organs. Symptoms include rashes, joint pain, anemia, ...

Systemic lupus erythematosus (lupus) is a chronic autoimmune disease that can affect any organ or tissue, including the skin, joints, heart, brain, lungs, and kidneys. The unpredictable nature of ...

In a new study, the drug, deucravacitinib, proved to be a safe and more effective treatment for cutaneous lupus erythematosus disease (CLE, lupus skin disease) than two other commonly used therapies, ...

After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib in a new trial shows that efficacy extends to cutaneous lupus.

Early initiation of hydroxychloroquine (HCQ) in patients with cutaneous lupus erythematosus (CLE) reduces the risk for progression to systemic lupus erythematosus (SLE) by 87% over time ...

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement. Systemic sclerosis (SSc) or scleroderma is another rheumatic autoimmune disease that ...